238 related articles for article (PubMed ID: 22856614)
1. ABO blood group, hypercoagulability, and cardiovascular and cancer risk.
Franchini M; Favaloro EJ; Targher G; Lippi G
Crit Rev Clin Lab Sci; 2012; 49(4):137-49. PubMed ID: 22856614
[TBL] [Abstract][Full Text] [Related]
2. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
[TBL] [Abstract][Full Text] [Related]
3. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
[TBL] [Abstract][Full Text] [Related]
4. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
Jenkins PV; O'Donnell JS
Transfusion; 2006 Oct; 46(10):1836-44. PubMed ID: 17002642
[TBL] [Abstract][Full Text] [Related]
5. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.
O'Donnell J; Laffan MA
Transfus Med; 2001 Aug; 11(4):343-51. PubMed ID: 11532189
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
[TBL] [Abstract][Full Text] [Related]
7. Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women.
Guimarães DA; dos Santos MS; Gomes KB; van der Bom JG; Rios DR; Cardoso J; Franco RM; Teixeira Gda S; Dusse LM; Carvalho Md; Fernandes AP
Menopause; 2012 Mar; 19(3):339-45. PubMed ID: 22089178
[TBL] [Abstract][Full Text] [Related]
8. ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia.
Cohen W; Castelli C; Alessi MC; Aillaud MF; Bouvet S; Saut N; Brunet D; Barthet MC; Tregouet DA; Lavigne G; Morange PE
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):2021-8. PubMed ID: 22628432
[TBL] [Abstract][Full Text] [Related]
9. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
10. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic.
Kawasaki T; Kaida T; Arnout J; Vermylen J; Hoylaerts MF
Thromb Haemost; 1999 Feb; 81(2):306-11. PubMed ID: 10064011
[TBL] [Abstract][Full Text] [Related]
11. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
Tirado I; Mateo J; Soria JM; Oliver A; Martínez-Sánchez E; Vallvé C; Borrell M; Urrutia T; Fontcuberta J
Thromb Haemost; 2005 Mar; 93(3):468-74. PubMed ID: 15735796
[TBL] [Abstract][Full Text] [Related]
12. ABO blood group and von Willebrand factor: biological implications.
Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
Clin Chem Lab Med; 2014 Sep; 52(9):1273-6. PubMed ID: 24945431
[TBL] [Abstract][Full Text] [Related]
13. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
Ay C; Thom K; Abu-Hamdeh F; Horvath B; Quehenberger P; Male C; Mannhalter C; Pabinger I
Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307
[TBL] [Abstract][Full Text] [Related]
14. Expresser phenotype determines ABO(H) blood group antigen loading on platelets and von Willebrand factor.
O'Donghaile D; Jenkins PV; McGrath RT; Preston L; Field SP; Ward SE; O'Sullivan JM; O'Donnell JS
Sci Rep; 2020 Oct; 10(1):18366. PubMed ID: 33110150
[TBL] [Abstract][Full Text] [Related]
15. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
[TBL] [Abstract][Full Text] [Related]
16. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.
Ward SE; O'Sullivan JM; O'Donnell JS
Blood; 2020 Dec; 136(25):2864-2874. PubMed ID: 32785650
[TBL] [Abstract][Full Text] [Related]
17. The effect of ABO blood group on von Willebrand response to exercise.
Ribeiro JL; Salton GD; Bandinelli E; Oliveira AR; Roisenberg I
Clin Appl Thromb Hemost; 2008 Oct; 14(4):454-8. PubMed ID: 18160595
[TBL] [Abstract][Full Text] [Related]
18. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.
Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I
Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554
[TBL] [Abstract][Full Text] [Related]
19. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.
Lison S; Dietrich W; Spannagl M
Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
